Your browser doesn't support javascript.
loading
Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation.
Lindsay, Julian; Sandaradura, Indy; Wong, Kelly; Arthur, Chris; Stevenson, William; Kerridge, Ian; Fay, Keith; Coyle, Luke; Greenwood, Matthew.
Afiliação
  • Lindsay J; Haematology Department, Royal North Shore Hospital, Sydney, Australia.
  • Sandaradura I; Department of Microbiology, St Vincent's Hospital, Sydney, Australia.
  • Wong K; University of New South Wales, Sydney, Australia.
  • Arthur C; Haematology Department, Royal North Shore Hospital, Sydney, Australia.
  • Stevenson W; Haematology Department, Royal North Shore Hospital, Sydney, Australia.
  • Kerridge I; Haematology Department, Royal North Shore Hospital, Sydney, Australia.
  • Fay K; Northern Blood Research Centre, Kolling Institute University of Sydney, Sydney, Australia.
  • Coyle L; Haematology Department, Royal North Shore Hospital, Sydney, Australia.
  • Greenwood M; Northern Blood Research Centre, Kolling Institute University of Sydney, Sydney, Australia.
J Antimicrob Chemother ; 72(12): 3414-3419, 2017 Dec 01.
Article em En | MEDLINE | ID: mdl-28961894

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Itraconazol / Quimioprevenção / Soro / Antifúngicos Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Itraconazol / Quimioprevenção / Soro / Antifúngicos Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália